Condition · Performance
Recovery from training
Evidence hub for recovery from training and related biohacking interventions.
01
Evidence-ranked peptides
| Peptide | Use | Evidence |
|---|---|---|
| Sermorelin Sermorelin is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials. | discussed_or_researched_for low_to_review | Human1/5 Animal0/5 Safety0/5 1 verified ref |
| IGF-1 LR3 IGF-1 LR3 is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials. | discussed_or_researched_for low_to_review | Human0/5 Animal2/5 Safety0/5 1 verified ref |
| PEG-MGF PEG-MGF is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials. | Recovery from training insufficient | Human0/5 Animal0/5 Safety0/5 1 verified ref |
| MGF MGF is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials. | Recovery from training insufficient | Human0/5 Animal0/5 Safety0/5 2 verified refs |
02
Current standard management
conventional medicineEvidence-based non-peptide options — including exercise, sleep, nutrition, physiotherapy and licensed medical treatments — often have stronger human evidence than research peptides.
Medical disclaimer —Standard-of-care information is educational only. Do not change or start treatment based on Atlas content. Always consult a qualified clinician for personal medical decisions.
04
Linked mechanisms
biological pathways discussed for this condition- MGF E-domain cell responselimited
- IGF-1 receptor signallinglimited
03
Community observations
No approved community reports for this condition yet. Submit one.
Clinician discussion
Questions you can ask a qualified clinician
- What are the established evidence-based options for this condition?
- What monitoring is appropriate before considering any experimental intervention?
- What long-term safety data exists for peptide-based approaches?
- Are there licensed medicines relevant to my situation?
↳